ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

TV Networks Donate A Prime-Time Hour To Raise Funds For Cancer Research; AACR To Administer Funds, Select Research “Dream Teams.”

May 30, 2008